| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 1 156-159, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JD Atkin, RJ Pleass, RJ Owens and JM Woof
Department of Pathology, University of Dundee, Ninewells Hospital, United Kingdom.
The structural features of the human IgA1 tailpiece required for interaction with J chain in IgA dimer assembly were investigated using a protein engineering approach. Wild-type and mutant forms of IgA1 were expressed in the mouse myeloma cell line, J558L, which endogenously expresses J chain. Wild-type IgA1 was secreted as a mixture of dimers and monomers. Deletion of the entire tailpiece by stop codon introduction completely prevented dimer formation. Similarly, substitution of the penultimate residue of the tailpiece, Cys471, with serine resulted in the secretion of IgA monomers alone. Substitution of Asn459 with alanine to prevent attachment of N-linked carbohydrate to the tailpiece also resulted in markedly reduced dimer assembly. These results indicate the critical role played by the tailpiece, and Cys471 in particular, in IgA dimerization. In addition, we found tailpiece- deleted IgA1 and the Cys to Ser471 mutant IgA1 were secreted as mixtures of covalently associated monomers (alpha 2L2) and alpha L half- molecules. The tailpiece may thus play some role in promoting the association of alpha-chains required for IgA monomer assembly.
This article has been cited by other articles:
|
|
 |
|
  A. Bonner, P. B. Furtado, A. Almogren, M. A. Kerr, and S. J. Perkins Implications of the Near-Planar Solution Structure of Human Myeloma Dimeric IgA1 for Mucosal Immunity and IgA Nephropathy J. Immunol., January 15, 2008; 180(2): 1008 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.J. Helmerhorst and F.G. Oppenheim Saliva: a Dynamic Proteome J. Dent. Res., August 1, 2007; 86(8): 680 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Baudino, L. Fossati-Jimack, C. Chevalley, E. Martinez-Soria, M. J. Shulman, and S. Izui IgM and IgA anti-erythrocyte autoantibodies induce anemia in a mouse model through multivalency-dependent hemagglutination but not through complement activation Blood, June 15, 2007; 109(12): 5355 - 5362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Senior and J. M. Woof Sites in the CH3 Domain of Human IgA1 That Influence Sensitivity to Bacterial IgA1 Proteases J. Immunol., September 15, 2006; 177(6): 3913 - 3919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Lewis, R. J. Pleass, M. R. Batten, J. D. Atkin, and J. M. Woof Structural Requirements for the Interaction of Human IgA with the Human Polymeric Ig Receptor J. Immunol., November 15, 2005; 175(10): 6694 - 6701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Royle, A. Roos, D. J. Harvey, M. R. Wormald, D. Van Gijlswijk-Janssen, E.-R. M. Redwan, I. A. Wilson, M. R. Daha, R. A. Dwek, and P. M. Rudd Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems J. Biol. Chem., May 23, 2003; 278(22): 20140 - 20153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Batten, B. W. Senior, M. Kilian, and J. M. Woof Amino Acid Sequence Requirements in the Hinge of Human Immunoglobulin A1 (IgA1) for Cleavage by Streptococcal IgA1 Proteases Infect. Immun., March 1, 2003; 71(3): 1462 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sorensen, I. B. Rasmussen, V. Sundvold, T. E. Michaelsen, and I. Sandlie Structural requirements for incorporation of J chain into human IgM and IgA Int. Immunol., January 1, 2000; 12(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Yoo, M. J. Coloma, K. R. Trinh, T. Q. Nguyen, L.-U. C. Vuong, S. L. Morrison, and K. R. Chintalacharuvu Structural Requirements for Polymeric Immunoglobulin Assembly and Association with J Chain J. Biol. Chem., November 19, 1999; 274(47): 33771 - 33777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Pleass, J. I. Dunlop, C. M. Anderson, and J. M. Woof Identification of Residues in the CH2/CH3 Domain Interface of IgA Essential for Interaction with the Human Fcalpha Receptor (Fcalpha R) CD89 J. Biol. Chem., August 13, 1999; 274(33): 23508 - 23514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Berdoz, C. T. Blanc, M. Reinhardt, J.-P. Kraehenbuhl, and B. Corthesy In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells PNAS, March 16, 1999; 96(6): 3029 - 3034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sorensen, V. Sundvold, T. E. Michaelsen, and I. Sandlie Polymerization of IgA and IgM: Roles of Cys309/Cys414 and the Secretory Tailpiece J. Immunol., March 15, 1999; 162(6): 3448 - 3455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hexham, K. D. White, L. N. Carayannopoulos, W. Mandecki, R. Brisette, Y.-S. Yang, and J. D. Capra A Human Immunoglobulin (Ig)A Calpha 3 Domain Motif Directs Polymeric Ig Receptor-mediated Secretion J. Exp. Med., February 15, 1999; 189(4): 747 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Mattu, R. J. Pleass, A. C. Willis, M. Kilian, M. R. Wormald, A. C. Lellouch, P. M. Rudd, J. M. Woof, and R. A. Dwek The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcalpha Receptor Interactions J. Biol. Chem., January 23, 1998; 273(4): 2260 - 2272. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
